This study, published in the American Journal of Preventive Medicine, investigated the associations between cannabis retail laws and relevant experiences (e.g., advertising exposure) among young adults, who have the highest use prevalence.

This dataset is longitudinal and displays key features of state-level statutes and regulations regarding buprenorphine prescribing for OUD outside of federally certified opioid treatment programs.

This dataset explores state and federal drug-induced homicide laws, highlighting variations in classification, sentencing, and legal elements across 52 jurisdictions from 2018–2019.

This dataset presents longitudinal data on state laws directing opioid litigation proceeds toward substance use disorder prevention, treatment, recovery, and harm reduction, highlighting policy surveillance utility.

This cross-sectional dataset provides an overview of state drug paraphernalia laws, focusing on how drug paraphernalia laws address access to drug checking equipment in all 50 states and the District of Columbia as of November 1, 2023.

This cross-sectional dataset provides an overview of state laws that decriminalize personal possession of controlled substances as of July 1, 2023.

This dataset examines the impact of incarceration on Medicaid status, including policies around Medicaid suspension and termination during incarceration, with a focus on public health challenges upon release.

This project identifies a series of 84 actionable steps for government at all levels to improve and align drug policy in the United States.

This longitudinal dataset captures US state laws from January 1, 2007, to January 1, 2023, that create an immunity or affirmative defense against drug-related criminal charges for individuals who call 911 to report an opioid overdose.

This dataset is cross-sectional and displays key features of approved state Section 1115 waivers.

This dataset examines state laws requiring informed consent for opioid prescriptions, detailing communication requirements, enforcement mechanisms, and population-specific regulations.

This dataset presents data on state PDMP laws from 2014–2019, detailing reporting mandates, provider requirements for database checks, and access regulations to address substance abuse and opioid use.

This dataset explores U.S. prescription drug monitoring program laws, detailing reporting requirements, database access, data retention, and penalties for unlawful disclosure.

This dataset explores state laws limiting opioid analgesic prescriptions, including duration, dosage, and restrictions for minors, highlighting variations and penalties across states.

This dataset tracks emerging legislation decriminalizing the possession of controlled substances across the U.S., focusing on bills and laws from January 2021 to August 2022, and provides policy recommendations.